Literature DB >> 11146903

External beam radiation therapy for prostate cancer.

E M Horwitz1, G E Hanks.   

Abstract

Men with non-metastatic prostate cancer have many treatment options. For over 35 years, radiation therapy has been a mainstay of treatment for this disease. With improvements in technology and better use of pretreatment prognostic factors, such as prostate specific antigen level and Gleason score, biochemical and clinical results have steadily improved. This article reviews the current status of radiation therapy in the treatment of prostate cancer. Results of treatment utilizing three-dimensional conformal and conventional techniques are compared and contrasted. The appropriate use of adjuvant hormones and particle beam therapy in the management of this disease is also discussed. Finally, the toxicity and future directions of radiation therapy in the treatment of prostate cancer are addressed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11146903     DOI: 10.3322/canjclin.50.6.349

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  4 in total

1.  Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.

Authors:  Richard M Hoffman; Linda C Harlan; Carrie N Klabunde; Frank D Gilliland; Robert A Stephenson; William C Hunt; Arnold L Potosky
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

2.  PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.

Authors:  L Chang; P H Graham; J Hao; J Ni; J Bucci; P J Cozzi; J H Kearsley; Y Li
Journal:  Cell Death Dis       Date:  2014-10-02       Impact factor: 8.469

3.  A retrospective study of late adverse events in proton beam therapy for prostate cancer.

Authors:  Hirokazu Makishima; Hitoshi Ishikawa; Keiichi Tanaka; Yutaro Mori; Masashi Mizumoto; Kayoko Ohnishi; Teruhito Aihara; Nobuyoshi Fukumitsu; Toshiyuki Okumura; Hideyuki Sakurai
Journal:  Mol Clin Oncol       Date:  2017-08-11

4.  Synergistic Effects of NDRG2 Overexpression and Radiotherapy on Cell Death of Human Prostate LNCaP Cells.

Authors:  M Alizadeh Zarei; M A Takhshid; A Behzad Behbahani; S Y Hosseini; M A Okhovat; Gh R Rafiee Dehbidi; M A Mosleh Shirazi
Journal:  J Biomed Phys Eng       Date:  2017-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.